Lipocine, Inc. (LPCN)
8.01
+0.48
(+6.37%)
USD |
NASDAQ |
Jan 09, 16:00
7.85
-0.16
(-2.00%)
After-Hours: 20:00
Lipocine EPS Diluted (Quarterly): -0.5887 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.187M |
| Revenue (Quarterly) | 0.1146M |
| Total Expenses (Quarterly) | 3.301M |
| Enterprise Value | 29.34M |
| Gross Profit Margin (Quarterly) | 87.70% |
| Profit Margin (Quarterly) | -2.78K% |
| Earnings Yield | -12.69% |
| Normalized Earnings Yield | -12.69 |